Electronic inhaler; In one of the first-of-its-kind studies, Cleveland Clinic researchers found that the use of electronic inhaler monitoring, in combination with a disease management program, is associated with reduced healthcare utilization in patients with chronic obstructive pulmonary disease (COPD). COPD is a term apply to a family of diseases that includes emphysema, chronic bronchitis,…
Asthma Affects; Mount Sinai was part of the largest clinical trial for asthma self management support in older patients, which resulted in improved control and quality of life, and fewer emergency department visits. Asthma affects 7% of Americans older than 65 and causes more symptoms and hospitalizations in this age group than in younger patients…
Tuberculosis Infection; In the first days after the tuberculosis (TB) bacteria infect the body, a flurry of immune cells are activate to fight the infection. Now, researchers have identify a master cell that coordinates the body’s immune defenses in those crucial early days, according to a new study from Washington University School of Medicine in…
Lung Cancer; Toxoplasma gondii, a microscopic parasite that gets inside our cells, is present in about 10% of the population in the U.K. But in tests on lung cancer patients, all were found to be infect with the parasite. It’s a remarkable result which we don’t fully understand yet, states Geoff Hide, Professor of Parasitology…
Entrectinib and Crizotinib are both active against ROS1+ non-small cell lung cancer. But which is best? The answer seems easy: Just compare the drugs’ clinical trial results. However, not all trials are created equal; so these differences in trial designs can lead to irrelevant comparisons; so like comparing athletes’ running times without noting that one…
Lung Cancer, Toxoplasma gondii, a microscopic parasite that gets inside our cells, is present in about 10% of the population in the UK. But in tests on lung cancer patients, all were find to be infect with the parasite. It’s a remarkable result which we don’t fully understand yet. It is possible that the presence of the…
Manuka honey could provide the key to a breakthrough treatment for cystic fibrosis patients following preliminary work by experts at Swansea University. Dr. Rowena Jenkins and Dr. Aled Roberts have found that using Manuka honey could offer an antibiotic alternative to treat antimicrobial resistant respiratory infections, particularly deadly bacteria found in Cystic Fibrosis (CF) infections. Using lung…
Researchers have made a breakthrough that could eventually lead to a more effective treatment for tuberculosis. Tuberculosis is one of the top 10 causes of death worldwide, according to the World Health Organization. A team of scientists, including Professor Colin Jackson from The Australian National University (ANU), has solve the mystery of how a cofactor…
Women with chronic obstructive pulmonary disease (COPD) appear to have a harder time than men with the progressive lung disorder, a new study suggests. Smoking is its leading cause, and while women report smoking less than men, those with COPD have more trouble breathing, more frequent flare-ups and a poorer quality of life, researchers find.…
A global study shows people born very preterm or with very low birth weight have a high risk of lung disease and are not reaching their full airway capacity by early adulthood. The research find those born before 32 weeks of pregnancy or with a birthweight of less than 1501g are four times more likely…
Dupilumab is associate with significantly reduce severe exacerbation rates in patients with late-onset asthma with or without fixed airway obstruction, according to a study present at the American Thoracic Society 2019 International Conference, held from May 17 to 22 in Dallas. Asthma is a condition in which your airways narrow and swell and produce extra…
Brigatinib is a next-generation ALK inhibitor that earned FDA approval in 2017 as a second line therapy after treatment with crizotinib for ALK-positive non-small cell lung cancer. Recently, clinical trial results published in the New England Journal of Medicine and presented at the 2018 World Conference on Lung Cancer show its promise as a first-line…